Bovine Antibody-Based Oral Immunotherapy for Reduction of Intragastric <i>Helicobacter pylori</i> Colonization: A Randomized Clinical Trial

Abstract

Bovine antibody-based oral immunotherapy appears to be safe, but does not significantly reduce intragastric density in humans. Further studies are needed to determine whether WPC treatment has additional value to conventional antibiotic treatment for H pylori.